Nonprofit Hospitals Took in Over $37 Billion in Tax Benefits in 2021
In 2021, the estimated total tax benefit received by U.S. nonprofit hospitals was $37.4 billion and was concentrated among a ...
More Healthcare Workers Tied to Missouri H5N1 Bird Flu Case Developed Symptoms
Four additional healthcare workers who cared for the Missouri patient confirmed to have H5N1 bird flu developed mild respiratory symptoms, ...
No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says
By way of two resoundingly consistent votes, members of an FDA advisory committee agreed that PD-1 inhibitors do not have ...
Hepatitis C in Pregnancy Increases NICU Admissions
TOPLINE: Maternal hepatitis C virus (HCV) infection is associated with a twofold increase in NICU admissions and nearly threefold increase in ...
Hurricane Prompts Heart Failure Society to Cancel Meeting
The Heart Failure Society of America (HFSA) has cancelled its annual scientific meeting, scheduled to begin today in Atlanta, Georgia, ...
Creating a ‘Healthier’ Health System: How Hard Could It Be?
David Nash is the Founding Dean Emeritus and Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at ...
Certain Oral Bacteria May Be a Risk Factor for Head and Neck Cancer
Researchers have identified a number of novel oral bacterial species that, taken together, appear to be a risk factor for ...
Map of the immune system changing with age may help optimise vaccines
The map of the immune system, with each dot representing an immune cell and dots of the same colour belonging ...
COVID Preventive Drug Should Work Against Circulating Variants, FDA Now Says
The FDA has determined that the monoclonal antibody pemivibart (Pemgarda) is likely to be effective against currently circulating SARS-CoV-2 variants, ...
Vaccine Hesitancy Is on the Rise. So Is Whooping Cough.
Kundu is a physician and a PhD student specializing in global surgery. Glatter is an assistant professor of emergency medicine. ...
First-Ever Biologic Approved for COPD
The FDA approved dupilumab (Dupixent) as the first biologic treatment for adults with chronic obstructive pulmonary disease (COPD), Sanofi and ...
Insurance Claim Denials for Preventive Care More Common in At-Risk Patients
Denials of insurance claims for preventive care were disproportionately more common among at-risk patient populations, including low-income patients, those with ...
FDA OKs First-in-Class Antipsychotic for Schizophrenia
The US Food and Drug Administration (FDA) has approved KarXT (Cobenfy; Bristol Myers Squibb), a first-in-class antipsychotic approved for schizophrenia. ...
SUID Rate Rose During the COVID-19 Pandemic
TOPLINE:Rates of sudden unexpected infant death (SUID) and sudden infant death syndrome (SIDS) increased during the COVID-19 pandemic, with the ...
New Hypertension Approach Hits Multiple Targets at Low Dose
LONDON — Single-pill combinations that include three or four antihypertensive medications are the way forward for the management of patients ...
Air Travel Alters Insulin Pump Delivery on Takeoff, Landing
MADRID — Airplane travel consistently causes insulin pumps to over-deliver a little over half a unit on takeoff and under-deliver ...
DTC Rheumatologic Tests Carry Some Benefit, Potential Risk
When Jennifer Welsh, a 40-year-old from New Britain, Connecticut, visited her doctor about pain in her joints and neck, her ...
FDA Approves First Novel Drug for Schizophrenia in Decades
The FDA on Thursday approved xanomeline and trospium chloride (Cobenfy) for schizophrenia in adults, the first new class of drug ...
‘Shed the Lead’ and the Injuries in the Cath Lab
"I'd probably be a quadriplegic," said Interventional Cardiologist Dean J. Kereiakes, MD, when asked what would have happened if two ...
Former NFL QB’s Dementia; Stem Cells Reverse Woman’s Diabetes; More Free COVID Tests
Note that some links may require registration or subscription. Former Minnesota Vikings quarterback Tommy Kramer revealed his dementia diagnosis. (AP ...
